- 601 South Church Street
Winston Salem, North Carolina 27101 - 3012500091
Glenn E McGee
Salem College, Health Sciences, Department Member
- Health Policy, Public Health, Bioethics, Pragmatism, Philosophy, Healthcare Economics, and 19 moreHealthcare Management, Genetics, John Dewey, William James, History of Science, Internet & Society, Environmental Studies, Edmund Husserl, Gene Therapy, Genetic Testing, Richard Zaner, John Lachs, Jean Bethke Elshtain, Scholarly Editing, Genomics, Big Data, Research Ethics, Biometrics, and Health Sciencesedit
- My most cited work deals with ethical issues in genetics, the compensation of research subjects, models for parenting... moreMy most cited work deals with ethical issues in genetics, the compensation of research subjects, models for parenting and enhancement, a pragmatic theory of bioethics, the patenting and sale of biological materials, ethical issues in tissue and gene banks, and ethical issues in stem cell research.
Until I joined Salem College in 2021, I served as Deputy Provost and previously as a Professor of Healthcare Administration and Policy, Management, and Philosophy at University of New Haven, where I taught from 2013-2019. My career began as assistant professor of medical ethics, cellular & molecular engineering, philosophy, and history & sociology of science at University of Pennsylvania from 1995-2005, where I was a Senior Fellow of the Leonard Davis Institute for Health Economics and the Associate Director for Education of the Penn Center for Bioethics. I then served as the John A. Balint Endowed Chair in Medical Ethics and Professor of Medicine at Albany Medical College of Union University, and as founding Director of the Alden March Bioethics Institute, a 7-institution bioethics research group. I was then the John B. Francis Endowed Chair in Bioethics (Center for Practical Bioethics, Kansas City, 2009-11).
I was Founding Editor-in-Chief of The American Journal of Bioethics (AJOB) from 1999-2011, during which time it became monthly, spawned a family of journals (AJOB Neuroscience and AJOB Primary Research), and achieved the highest impact factor in the fields of bioethics and of health policy.
I have given a number of named and/or endowed lectureships and have testified before US House and Senate committees and several state legislatures, primarily on measures involving stem cell research, cloning and ART. I also co-authored text that was eventually adopted in laws regarding stem cells, and my speech to the CA cloning commission is the Representative American Speeches volume.
I have provided commentary for the media, including All Things Considered, Frontline, Today Show, Anderson Cooper 360, Good Morning America, 60 Minutes, and most major US and European newspapers and wire services. I have authored regular columns for The Scientist and for MSNBC.
I was honored by the U.S. FDA for distinguished service on its Panel on Molecular and Genetic Devices. I was awarded an Atlantic Fellowship in Public Policy by the UK to study comparative international stem cell policy. In 2007 I served for the UK ESRC as external evaluator of UK genetics & policy programs. I served on two National Human Genome Research Institute ELSI working groups, two working groups of the US Centers for Disease Control, and several study sections of the NIH, and was invited to serve as US reviewer for national funding for ethics in genome sciences in Canada. I served on the bodies regulating newborn screening in New York State and later in Kansas.
James Fossett of Rockefeller Institute and I created the nation’s first program devoted to "states, federalism and bioethics," where our first study was of stem cell policy in the US and Europe. I was also the first Chair of the Ethics Advisory Board of Advanced Cell Technology, Inc.
I graduated from Baylor (BA), Vanderbilt (MA, PhD), and completed a post-doctoral fellowship in genetics from US National Human Genome Research Institutes of NIH, at University of Iowa. In 2000 I was honored that Baylor named me an outstanding young alumnus, and in 2008 one of Baylor's “top 150 graduates". I grew up in Waco, Texas and was a high school debater at Richfield High School.edit
Glenn McGee constantly breathes life into bioethics by ferreting out the interesting, the unusual, and the important ethical issues. Bioethics for Beginners is a brilliant introduction to the ethical issues that make science really... more
Glenn McGee constantly breathes life into bioethics by ferreting out the interesting, the unusual, and the important ethical issues. Bioethics for Beginners is a brilliant introduction to the ethical issues that make science really interesting, and a masterfully written read that combines scholarship, humor and humility.
-Chris Mooney, author, The Republican War on Science and The Republican Brain
In a concise and matter-of-fact fashion, McGee stacks explosive issue upon explosive issue, from abhorrent clinical trials to the radical research that undermines our sense of humanity. An essential guide to the bioethics powder keg.
-Richard Gallagher, Editor-in-Chief at Lives: New Answers for Global Health and co-founder of Hopeful Monster Publishing
-Chris Mooney, author, The Republican War on Science and The Republican Brain
In a concise and matter-of-fact fashion, McGee stacks explosive issue upon explosive issue, from abhorrent clinical trials to the radical research that undermines our sense of humanity. An essential guide to the bioethics powder keg.
-Richard Gallagher, Editor-in-Chief at Lives: New Answers for Global Health and co-founder of Hopeful Monster Publishing
Research Interests:
Publishers Weekly: "Prominent bioethicist McGee urges readers to get smart about their DNA before it's too late in this genetic answer to Nicholas Negroponte's Being Digital. For instance, the author writes, though we would never leave... more
Publishers Weekly: "Prominent bioethicist McGee urges readers to get smart about their DNA before it's too late in this genetic answer to Nicholas Negroponte's Being Digital. For instance, the author writes, though we would never leave our ATM code where someone could read it, we "think nothing of leaving bits of blood and tissue in the emergency room of a major hospital that is sure to conduct research on it." In decades past, questions of genetics were answered by "appeals to natural law theory," and often led to discrimination, injustice and even genocide. But the very notion of heredity has become obsolete in the new world McGee describes; instead, scientists are about to offer reproductive choices beyond our imaginings, cure diseases and feed billions more people-all while making astonishing amounts of money from "our" genes. In rapid-fire chapters packed with references to news stories and scientific studies, McGee outlines new developments in genetic testing, gene therapy and genetically modified food organisms. Just as personal computers have brought the digital revolution into our daily lives, home diagnostic kits will let us (or force us to) take charge of our own genes. "You'll update your medicine cabinet the way you update your computer software," writes McGee. Our food, drugs and children will all be subject to genetic analysis and modification. This book is something of a scattered cautionary lecture, veering off into corporate tactics, legalities and personal anecdotes, but McGee makes his point in the end, offering a heads-up assessment of how advances in genetic research are sure to complicate our lives."
Booklist: "Pitched to readers who take genetics personally, wondering what all those headlines about the Human Genome Project mean for my genome, McGee presents in effect an owner's manual. He anticipates the development of technology born of the marriage between computer power and DNA mapping that will enable the ordinary person to access their personal genome. But McGee, a bioethicist, asks several questions. Do you really want to know what your DNA codes are? Is your physician competent enough to tell you? For most people, their main concern will be whether their DNA harbors genes indicating susceptibility to a disease for themselves or their progeny. And if it does, should you let bio-entrepreneurs have your DNA, so they can develop tests and cures for the disease? Outlining the ethical thickets, including the patenting of genes, McGee gives clear understanding of vital considerations in deciding whether to perform a test, undergo infertility treatment, or chow down on genetically manufactured food. Health-conscious readers will close McGee's book more informed and, perhaps, less worried."
Booklist: "Pitched to readers who take genetics personally, wondering what all those headlines about the Human Genome Project mean for my genome, McGee presents in effect an owner's manual. He anticipates the development of technology born of the marriage between computer power and DNA mapping that will enable the ordinary person to access their personal genome. But McGee, a bioethicist, asks several questions. Do you really want to know what your DNA codes are? Is your physician competent enough to tell you? For most people, their main concern will be whether their DNA harbors genes indicating susceptibility to a disease for themselves or their progeny. And if it does, should you let bio-entrepreneurs have your DNA, so they can develop tests and cures for the disease? Outlining the ethical thickets, including the patenting of genes, McGee gives clear understanding of vital considerations in deciding whether to perform a test, undergo infertility treatment, or chow down on genetically manufactured food. Health-conscious readers will close McGee's book more informed and, perhaps, less worried."
Research Interests:
The best book for those perplexed by the philosophical and ethical conundrums of genetics in the 21st century. (CHOICE) McGee develops a very powerful line of reasoning about genetic enhancement. (The Philadelphia Inquirer) He... more
The best book for those perplexed by the philosophical and ethical conundrums of genetics in the 21st century. (CHOICE)
McGee develops a very powerful line of reasoning about genetic enhancement. (The Philadelphia Inquirer)
He combines a rich body of clinical material with informed pragmatic critique. (Mary Briody Mahowald, University of Chicago)
A pioneering, landmark work in pragmatic bioethics. (John J. Stuhr, Head of the Department of Philosophy, Penn State University)
This captivating book offers balanced new insights for individual decisions and for public policy. (John Lachs, Centennial Professor of Philosophy, Vanderbilt University)
A welcome alternative to work that force fits the issues either to scholarly abstractions or to myths of popular culture. (Caroline Whitbeck, Ethics Center for Engineering & Science, MIT)
A provocative account of this emerging, cutting-edge issue that will greatly profit future commentators and policymakers. (John Robertson, School of Law, University of Texas)
A useful road map as we enter the complex territory of genetic medicine in the 21st century. (James M. Wilson, director, Institute for Human Gene Therapy, University of Pennsylvania)
A remarkably well-informed and sensitive exploration of the opportunities and challenges presented by the new science of genetics. (Jonathan D. Moreno, State University of New York, Brooklyn)
Extremely readable and provocative . . . succeeds at something that few scholars in Bioethics have even attempted: to speak in ordinary language and in a conversational voice about the nest of subtle issues that entangle new advances in human genetics. (Eric Juengst, Ph.D. Center for Biomedical Ethics, School of Medicine)
McGee is one of the most energetic and inquisitive writers in the emerging 'next generation' of bioethicists . . . His work is interesting, important, and has the kind of self-reflective courage we need to face these issues squarely. (Margaret P. Battin, University of Utah)
McGee's application of the pragmatic method to issues in bioethics is both timely and effective. McGee's excellent final chapters will give students of all levels a perspective that cannot be found in other books of the kind. (Teaching Philosophy)
McGee's book breathes all the virtues of a pioneering work. it puts the issue of human genetic engineering in a fresh perspective, draws the attention to many valuable points, and raises a number of important questions. (Cornelis de Waal, Newsletter of the Society for the Advancement of American Philosophy Newsletter Of The Society For The Advancement Of American)
McGee's well-written and intriguing new book adds little to the content . . . .he does offer a unique and much needed practical approach to the critical analysis of the relevant issues. (Timothy Caulfield, Universtiy of Alberta Phil Review, Vol. Xvii N0.. 4-6 Aug.-Dec. 97)
McGee's book is an excellent introduction to the issues and he provides especially good treatments of the nature/nurture debate and the relationship between genetics and allocation decisions. Many will find his views provocative. His work is breezy and fun to read. (L.M.P. Ethics, Jan. 1998)
So where do ordinary folk, faced with a life-or-death decision, get some useful information? This book might be a good starting ground. (Beverly Kelley, California Lutheran University Sunday, June 29, 1997)
The philosophical tradition of American pragmatism has had a fresh life in recent years. In McGee's hands it is richer, more suggestive . . . Not everyone will find The Perfect Baby acceptable, but McGee will give the opponents reason to pause. Weneed that kind of initiative, and McGee's book will provoke some useful, much needed debate. (Daniel Callahan, The Hastings Center)
Finally— a good book about genetics— that makes these fascinating issues understandable to the families who need to know. (N. P. R.'S Voices In The Family)
. . . useful to just about everyone who must grapple with the new genetics. (The Washington Times)
The book is appropriately directed to a diverse audience and makes refreshing use of plain language to address relevant issues present in the choices we must now make in everyday life. (Bruce C. Trafnell, Genetic Therapy, Inc. Dept. of Virology Nature Medicine, Vol. 3 No. 6)
McGee develops a very powerful line of reasoning about genetic enhancement. (The Philadelphia Inquirer)
He combines a rich body of clinical material with informed pragmatic critique. (Mary Briody Mahowald, University of Chicago)
A pioneering, landmark work in pragmatic bioethics. (John J. Stuhr, Head of the Department of Philosophy, Penn State University)
This captivating book offers balanced new insights for individual decisions and for public policy. (John Lachs, Centennial Professor of Philosophy, Vanderbilt University)
A welcome alternative to work that force fits the issues either to scholarly abstractions or to myths of popular culture. (Caroline Whitbeck, Ethics Center for Engineering & Science, MIT)
A provocative account of this emerging, cutting-edge issue that will greatly profit future commentators and policymakers. (John Robertson, School of Law, University of Texas)
A useful road map as we enter the complex territory of genetic medicine in the 21st century. (James M. Wilson, director, Institute for Human Gene Therapy, University of Pennsylvania)
A remarkably well-informed and sensitive exploration of the opportunities and challenges presented by the new science of genetics. (Jonathan D. Moreno, State University of New York, Brooklyn)
Extremely readable and provocative . . . succeeds at something that few scholars in Bioethics have even attempted: to speak in ordinary language and in a conversational voice about the nest of subtle issues that entangle new advances in human genetics. (Eric Juengst, Ph.D. Center for Biomedical Ethics, School of Medicine)
McGee is one of the most energetic and inquisitive writers in the emerging 'next generation' of bioethicists . . . His work is interesting, important, and has the kind of self-reflective courage we need to face these issues squarely. (Margaret P. Battin, University of Utah)
McGee's application of the pragmatic method to issues in bioethics is both timely and effective. McGee's excellent final chapters will give students of all levels a perspective that cannot be found in other books of the kind. (Teaching Philosophy)
McGee's book breathes all the virtues of a pioneering work. it puts the issue of human genetic engineering in a fresh perspective, draws the attention to many valuable points, and raises a number of important questions. (Cornelis de Waal, Newsletter of the Society for the Advancement of American Philosophy Newsletter Of The Society For The Advancement Of American)
McGee's well-written and intriguing new book adds little to the content . . . .he does offer a unique and much needed practical approach to the critical analysis of the relevant issues. (Timothy Caulfield, Universtiy of Alberta Phil Review, Vol. Xvii N0.. 4-6 Aug.-Dec. 97)
McGee's book is an excellent introduction to the issues and he provides especially good treatments of the nature/nurture debate and the relationship between genetics and allocation decisions. Many will find his views provocative. His work is breezy and fun to read. (L.M.P. Ethics, Jan. 1998)
So where do ordinary folk, faced with a life-or-death decision, get some useful information? This book might be a good starting ground. (Beverly Kelley, California Lutheran University Sunday, June 29, 1997)
The philosophical tradition of American pragmatism has had a fresh life in recent years. In McGee's hands it is richer, more suggestive . . . Not everyone will find The Perfect Baby acceptable, but McGee will give the opponents reason to pause. Weneed that kind of initiative, and McGee's book will provoke some useful, much needed debate. (Daniel Callahan, The Hastings Center)
Finally— a good book about genetics— that makes these fascinating issues understandable to the families who need to know. (N. P. R.'S Voices In The Family)
. . . useful to just about everyone who must grapple with the new genetics. (The Washington Times)
The book is appropriately directed to a diverse audience and makes refreshing use of plain language to address relevant issues present in the choices we must now make in everyday life. (Bruce C. Trafnell, Genetic Therapy, Inc. Dept. of Virology Nature Medicine, Vol. 3 No. 6)
Research Interests:
"McGee's Pragmatic Bioethics theory is the first new theory of bioethics of consequence in 20 years, and arguably our best hope to provide morally satisfying answers to the complex questions of a contingent and changing world. This volume... more
"McGee's Pragmatic Bioethics theory is the first new theory of bioethics of consequence in 20 years, and arguably our best hope to provide morally satisfying answers to the complex questions of a contingent and changing world. This volume approaches medicine's major moral dilemmas in a way that can help citizens work with policymakers to develop medical systems, structures, guidelines, and codes that serve the interests of most of the people most of the time. What an accomplishment!" Rosemarie Tong, Distinguished Professor of Health Care Ethics, University of North Carolina at Charlotte
Research Interests:
In 1997 Scottish biologist Ian Wilmut successfully cloned a sheep, Dolly, in a controversial act many perceived as the first step toward human cloning. The Human Cloning Debate is the first book to present Wilmut's own thoughts on the... more
In 1997 Scottish biologist Ian Wilmut successfully cloned a sheep, Dolly, in a controversial act many perceived as the first step toward human cloning. The Human Cloning Debate is the first book to present Wilmut's own thoughts on the troubling ramifications of this technology, along with essays by experts who explore the history and techniques of cloning, ethical issues, and the future possibilities. Its first edition was chosen as one of The New York Times's Top 100 Books for 1998. The 2004 edition, co-edited with Arthur Caplan, represents a complete re-working of the text and is a definitive treatment of both the history of this phenomenon and its ethical implications, suitable for classroom and researcher.
Research Interests:
With the mapping of the human genome and the development of cloning and other genetic engineering techniques, scientists have embarked upon a whole new era of biomedical research and with it a maze of complex ethical and legal questions.... more
With the mapping of the human genome and the development of cloning and other genetic engineering techniques, scientists have embarked upon a whole new era of biomedical research and with it a maze of complex ethical and legal questions. Do isolated gene sequences constitute ôinventionsö that warrant patent protection? What about cloned organisms, or new life forms engineered from pre-existing tissue? Do scientists have the right to claim individual patents on and make profits from the elements of life? How does the profit motive affect our attitudes toward the value of life? Will patent protection foster or hinder scientific cooperation and research into diseases? These are a few of the vexing questions that must be faced in the coming decades as biotechnology advances into uncharted ethical territory.
This excellent collection of articles by scientists, ethicists, and legal experts analyzes the convergence of biotechnology and intellectual property legislation, which has given rise to these new moral dilemmas. It will serve as a valuable reference work to give educated lay readers a starting point to make their own judgments about matters we will all face in the near future.
This excellent collection of articles by scientists, ethicists, and legal experts analyzes the convergence of biotechnology and intellectual property legislation, which has given rise to these new moral dilemmas. It will serve as a valuable reference work to give educated lay readers a starting point to make their own judgments about matters we will all face in the near future.
Research Interests:
This work presents preliminary forensic analysis of two popular smart watches, the Samsung Gear 2 Neo and LG G. These wearable computing devices have the form factor of watches and sync with smart phones to display notifications, track... more
This work presents preliminary forensic analysis of two popular smart watches, the Samsung Gear 2 Neo and LG G. These wearable computing devices have the form factor of watches and sync with smart phones to display notifications, track footsteps and record voice messages. We posit that as smart watches are adopted by more users, the potential for them becoming a haven for digital evidence will increase thus providing utility for this preliminary work. In our work, we examined the forensic artifacts that are left on a Samsung Galaxy S4 Active phone that was used to sync with the Samsung Gear 2 Neo watch and the LG G watch. We further outline a methodology for physically acquiring data from the watches after gaining root access to them. Our results show that we can recover a swath of digital evidence directly form the watches when compared to the data on the phone that is synced with the watches. Furthermore, to root the LG G watch, the watch has to be reset to its factory settings which is alarming because the process may delete data of forensic relevance. Although this method is forensically intrusive, it may be used for acquiring data from already rooted LG watches. It is our observation that the data at the core of the functionality of at least the two tested smart watches, messages, health and fitness data, e-mails, contacts, events and notifications are accessible directly from the acquired images of the watches, which affirms our claim that the forensic value of evidence from smart watches is worthy of further study and should be investigated both at a high level and with greater specificity and granularity.
Research Interests:
Argument regarding genetic exceptionalism as it applies to gene therapy and gene transfer research. Pre-publication print.
Research Interests:
This work presents preliminary forensic analysis of two popular smart watches, the Samsung Gear 2 Neo and LG G. These wearable computing devices have the form factor of watches and sync with smart phones to display notifications, track... more
This work presents preliminary forensic analysis of two popular smart watches, the Samsung Gear 2 Neo and LG G. These wearable computing devices have the form factor of watches and sync with smart phones to display notifications, track footsteps and record voice messages. We posit that as smart watches are adopted by more users, the potential for them becoming a haven for digital evidence will increase thus providing utility for this preliminary work. In our work, we examined the forensic artifacts that are left on a Samsung Galaxy S4 Active phone that was used to sync with the Samsung Gear 2 Neo watch and the LG G watch. We further outline a methodology for physically acquiring data from the watches after gaining root access to them. Our results show that we can recover a swath of digital evidence directly form the watches when compared to the data on the phone that is synced with the watches. Furthermore, to root the LG G watch, the watch has to be reset to its factory settings which is alarming because the process may delete data of forensic relevance. Although this method is forensically intrusive, it may be used for acquiring data from already rooted LG watches. It is our observation that the data at the core of the functionality of at least the two tested smart watches, messages, health and fitness data, e-mails, contacts, events and notifications are accessible directly from the acquired images of the watches, which affirms our claim that the forensic value of evidence from smart watches is worthy of further study and should be investigated both at a high level and with greater specificity and granularity.
Research Interests:
Reproductive mitochondrial transplantation (RMT) allows women who are not (typically) infertile but carry heritable diseases of the mitochondria to reproduce by inseminating eggs that contain their own nuclear DNA as well as mitochondrial... more
Reproductive mitochondrial transplantation (RMT) allows women who are not (typically) infertile but carry heritable diseases of the mitochondria to reproduce by inseminating eggs that contain their own nuclear DNA as well as mitochondrial DNA ‘transplanted’ from the egg of another woman. The British approval of RMT is new, but embryos were made from 1996 and offspring in 2003 (McGee 1998, 2003). The goal articulated by UK regulatory agencies is “the chance of having a healthy child” (HFEA 2013). However a healthychild may be had without RKM; prospective RMK candidates seek to birth a child with the maximum amount of genetic similarity, trading off unknown risk of adding genetic material of a third person in order to avoid known risk of heritable mitochondrial disease.
In the domain of public health, resource allocation for treatment of infertility is seen from a different but useful perspective. Is a societal-level commitment to RKM consistent with best reproductive, maternal, and child health practice and policy? Costs associated with developing, providing and regulating assisted reproductive technologies have skyrocketed, and the decision in the U.K. to allow patients to consume public resources for RKM presents an opportunity to analyze the future of reproductive health. Are parents who are able to have children ‘alone’ only if they pass a known, lethal disease entitled to public resources for ‘infertility’ treatments? I assess the goal of ‘genetic similarity’ in the context of public health principles of healthy reproductive outcomes.
In the domain of public health, resource allocation for treatment of infertility is seen from a different but useful perspective. Is a societal-level commitment to RKM consistent with best reproductive, maternal, and child health practice and policy? Costs associated with developing, providing and regulating assisted reproductive technologies have skyrocketed, and the decision in the U.K. to allow patients to consume public resources for RKM presents an opportunity to analyze the future of reproductive health. Are parents who are able to have children ‘alone’ only if they pass a known, lethal disease entitled to public resources for ‘infertility’ treatments? I assess the goal of ‘genetic similarity’ in the context of public health principles of healthy reproductive outcomes.
Research Interests:
The regulation of e-cigarettes and the e-liquids they deliver has proved challenging for the US Food and Drug Administration given the relatively short time these products have been widely distributed and the inconclusive data about their... more
The regulation of e-cigarettes and the e-liquids they deliver has proved challenging for the US Food and Drug Administration given the relatively short time these products have been widely distributed and the inconclusive data about their effects on human health. While conventional tobacco cigarette use continues to drop among adults and teenagers, e-cigarette use has skyrocketed, particularly among school aged children and young adults.
Research Interests:
Research Interests:
Glenn McGee, Editor-in-chief of the American Journal of Bioethics offers a brief overview of the issues that have defined America's 'thirty years of bioethic,' and contends that genetics is the issue that now awakens... more
Glenn McGee, Editor-in-chief of the American Journal of Bioethics offers a brief overview of the issues that have defined America's 'thirty years of bioethic,' and contends that genetics is the issue that now awakens bioethicists' concern.
Research Interests:
Research Interests:
Research Interests:
... to the agency. The revelation hits Merck right where it hurts: the company, still reeling from the Vioxx scandal, has created with Gardasil what should be the safest vaccine ever made, but which now may pose significant risks. ...
Research Interests:
... is. And it doesn't give policy makers in Utah or Washington or New Delhi a way to integrate the most-published bio-ethics articles ... dent would appoint such a panel is no surprise; it follows in the tradition of John F.... more
... is. And it doesn't give policy makers in Utah or Washington or New Delhi a way to integrate the most-published bio-ethics articles ... dent would appoint such a panel is no surprise; it follows in the tradition of John F. Kennedy's Camelot strategy of assembling national panels of ...
Research Interests:
Research Interests:
Most commentators on the Terri Schiavo case do not realize that nutritional issues played a huge role not only at the end of her life - with debates about food and water as a treatment to be withdrawn - but also when she had her heart... more
Most commentators on the Terri Schiavo case do not realize that nutritional issues played a huge role not only at the end of her life - with debates about food and water as a treatment to be withdrawn - but also when she had her heart attack, which was very likely because of bulimia. The bioethics community has mostly missed this important connection.
Research Interests:
h-index 24, i10 index 38
Research Interests: Bioethics and Federalism
Research Interests:
Research Interests:
Research Interests:
Bitcoin promises to revolutionize currency or even money. It has provoked debate primarily about its own legitimacy, but among those who study and traffic in it there is a larger and more interesting conversation about the meaning of... more
Bitcoin promises to revolutionize currency or even money. It has provoked debate primarily about its own legitimacy, but among those who study and traffic in it there is a larger and more interesting conversation about the meaning of money, the stability of currency, the politics of cryptographic transfer, and many other issues. The creation of a single class about bitcoin at NYU made me wonder: what if bitcoin could be used as a broader platform to engage students in experiential education?
Research Interests:
Research Interests: Marketing, Genetics, Sociology, Anthropology, Ethics, and 16 moreGenetic Epidemiology, Privacy, Informed Consent, Public Health, Iceland, Social Science & Medicine, Commerce, Population, Humans, Population Studies, Data Collection, Human Genome Project, Genome, Scientific Research, Public health systems and services research, and Population Study
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests: Philosophy, Ethics, Applied Ethics, Government, Stem Cells, and 22 morePolitics, Social Justice, Risk, Risk assessment, Cryopreservation, Research, Stem Cell, Empathy, Social Welfare, Humans, Life, Federal Government, United States, Embryo Research, Kennedy, Morals, Complicity, Risk Assessment, Fetus, Value of Life, Kennedy Institute of Ethics, and Public Policy
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Help is wanted. There are more than 78 bioethics-related job openings noted in the December 2002 bioethics. net 'positions available'list: currently available are professorships of all rank in medical schools,... more
Help is wanted. There are more than 78 bioethics-related job openings noted in the December 2002 bioethics. net 'positions available'list: currently available are professorships of all rank in medical schools, administrator jobs on corporate Institutional Review Boards, ...
Research Interests:
Research Interests: Applied Ethics, Bioethics, Research Design, Trust, Eating Disorders, and 25 moreInformed Consent, Euthanasia, Risk assessment, Starvation, Deception, Social behavior, Oxytocin, Humans, Character, Weight Loss, Female, Terri Schiavo, Myocardial Infarction, Adult, Public health systems and services research, Body Weight, Risk Assessment, Social Behavior, Behavioral Research, Bulimia, Weight Gain, Behavior Control, Choice Behavior, Enteral Nutrition, and The American
Research Interests:
Research Interests:
Research Interests:
In retrospect, in 1997 as an assistant professor at the Uni-versity of Pennsylvania, I was neither old enough nor wise enough to undertake the creation of a scholarly journal. Yet, as those who know me would expect, I did it anyway.... more
In retrospect, in 1997 as an assistant professor at the Uni-versity of Pennsylvania, I was neither old enough nor wise enough to undertake the creation of a scholarly journal. Yet, as those who know me would expect, I did it anyway. Whatever my peers at American Journal of ...
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests: Genetics, Pragmatism, Bioethics, Genomics, Health Law, and 3 moreCloning, Genome Project, and Yale Law School
Each year, the President of the University of New Haven selects a professor to give a "Last Lecture." The challenge is to offer a talk that would, in the speaker's view, be appropriate if it were the last lecture they could ever give.... more
Each year, the President of the University of New Haven selects a professor to give a "Last Lecture." The challenge is to offer a talk that would, in the speaker's view, be appropriate if it were the last lecture they could ever give. Glenn McGee was selected to give the lecture for 2016. The title of his lecture is "Lost"; its premise is that our digital identities are far more easily lost than we realize.
Research Interests:
A brief analysis of the story from Plato's Republic and relevant texts in philosophy, history and sociology of medicine as they bear on the odd matter of trust in clinical relationships
Research Interests:
Continuing an introductory exploration of the way that sociologists, anthropologists and philosophers of medicine have framed the question of how patients' perceptions of healthcare environments are changing and the role of strangers in... more
Continuing an introductory exploration of the way that sociologists, anthropologists and philosophers of medicine have framed the question of how patients' perceptions of healthcare environments are changing and the role of strangers in that environment.
Research Interests:
A continuation of a 2012 introduction to the role of social values, including financial exigency, in hospitals' and clinicians' approaches to decision making about care at several levels, including the bedside, the community and the... more
A continuation of a 2012 introduction to the role of social values, including financial exigency, in hospitals' and clinicians' approaches to decision making about care at several levels, including the bedside, the community and the hospital's economic role. Framed as a question for clinical ethics, the goal of the short lecture is to situate the clinical encounter within the perceptions of new professionals in the medical world including ethicists.
Research Interests:
Research Interests:
Introduction to living wills and advance directives
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests: German Studies, Ethics, Bioethics, History Of Eugenics, History of Medicine, and 11 moreHistory of Science, Race and Ethnicity, Medical Ethics, Holocaust Studies, Perfectionism, Moral Philosophy, Bioethics Reproductive Technology, Genetic Engineering, Eugenics, Holocaust and Genocide Studies, and Center for Practical Bioethics
Research Interests:
Research Interests:
Research Interests: Program Evaluation, Ethics, Applied Ethics, Research Ethics, Health Care, and 14 morePolitical Science, Accreditation, Medicine, Clinical Ethics, Humans, Hospital administration, United States, Cambridge, Questionnaires, Commission, Mandate, Hospital Accreditation, Random Allocation, and Health Care Surveys
Research Interests:
Pluripotent human stem cell research may offer new treatments for hundreds of diseases, but opponents of this research argue that such therapy comes attached to a Faustian bargain: cures at the cost of the destruction of many frozen... more
Pluripotent human stem cell research may offer new treatments for hundreds of diseases, but opponents of this research argue that such therapy comes attached to a Faustian bargain: cures at the cost of the destruction of many frozen embryos. The National Bioethics Advisory Commission (NBAC), government officials, and many scholars of bioethics, including, in these pages, John Robertson, have not offered an adequate response to ethical objections to stem cell research. Instead of examining the ethical issues involved in sacrificing human embryos for the goal of curing fatal and disabling diseases, they seek to either dismiss the moral concerns of those with objections or to find an "accomodation" with those opposed to stem cell research. An ethical argument can be made that it is justifiable to modify or destroy certain human embryos in the pursuit of cures for dread and lethal diseases. Until this argument is made, the case for stem cell research will rest on political foundations rather than on the ethical foundations that the funding of stem cell research requires.
Research Interests:
It is hard to dispute some of the conclusions of Geron's Ethics Advisory Board: stem cell research holds medical promise, is morally problematic, and suggests a need for careful political oversight to ensure responsible progress, the... more
It is hard to dispute some of the conclusions of Geron's Ethics Advisory Board: stem cell research holds medical promise, is morally problematic, and suggests a need for careful political oversight to ensure responsible progress, the support of the public, and the fair distribution of benefits and costs. And as participants ourselves in several corporate efforts to develop ethical standards for research and oversight mechanisms within biotechnology, we applaud Geron for sponsoring a position statement on moral issues. The effort of the Geron EAB participants to walk a fine line between sponsored research and apologetics is also commendable. However, there is a long way to go, both in developing bioethical review of corporate-based science and in encouraging moral analysis of stem cell research. One area where Geron's brief report needs work is in elaborating the subtle issues associated with the moral status of human stem cells. As reported by the EAB and in Science, Geron investigators' research into human embryonic stem cells (hES) has resulted already in the successful isolation and establishment of cell lines. Such research holds great promise for tissue transplantation, gene therapy, pharmaceutical development, and human embryology. Human and transgenic stem-cell-based research also promises a secondary wave of progress in related areas of science and technology--the "double effect" of stem cell research. For example, while Geron's and other teams working on stem cells may not be directly invested in reproductive genetics, one likely effect of Geron's work would be the acceleration of research on reproductive cloning. In their report, the EAB distinguishes between stem cell research that involves cells derived from blastocysts and research that involves cells from fetal tissue obtained from an abortus. We do not quibble with EAB's view of the issues involving tissue from aborted fetuses. However, its defense of hES research on blastocyst-derived cells is insufficient. The report argues that the moral status of a human, and thus our responsibility to a developing embryo and fetus, grows in strict relation to its development. It accepts what EAB member Ted Peters (following dozens of others in genetics and ethics) terms a "developmental" approach according to which, roughly, an embryo gets more status as it becomes more like a person, with the transition to blastocyst marking an important jump. The developmental approach to embryo status appears helpful on its face. After all, it links moral status to scientifically ascertainable developments. It recognizes that capacities and potential are both important in deciding whether an entity has rights or other moral standing, and it distinguishes between material that is "headed" for human personhood and material that is merely a repository of some component of personhood. It also distinguishes, or could, between tissues in vivo and tissue stored on ice. Most importantly, it is (or at least Peters claims it is) a threshold concept, roughly separating material that can be thought of as an end in itself from material that is merely a means to some other end. Moral Status and Context However, in the work of the EAB, the idea of development as a moral barometer does nothing to clear up the moral issues faced by those who work on stem cells. Worse, it rests on a conceptual confusion that must be resolved before progress can be made in this area of research more generally. Embryonic and germ cell status is not a scientific matter. There is neither consensus nor fact from which to deduce the social meaning of different embryonic or fetal tissues. In fact, hES research, and other basic research on reproduction, radically enlarges the problem of defining basic facts about embryos. We call this problem one of determining "what is in the petrie dish." It is a problem with two parts. First, it is becoming possible to isolate and separate human germ cells and embryonic/fetal tissues from their ordinary environments. …
Research Interests:
Research Interests: Stem Cells, Biology, Medical Ethics, Medicine, Humans, and 6 moreUnited States, Pubmed, Doors, WJM, Embryo disposition, and Western medicine
Research Interests:
Research Interests: Applied Ethics, Bioethics, Medical Ethics, Medicine, Clinical Ethics, and 14 moreSocial Responsibility, Clinical ethics consultation, Humans, North Carolina, Role, Philadelphia, Professional Practice, Certification, Patient Care Team, Cambridge Quarterly, Presumption, Professional Role, hospital units, and Referral and consultation
... 234 Glenn McGee, Jessica Anchor and Arthur Caplan easy money. Barbara Nevins writes, for example, of one college student who had a credit card bill of $3000, prompting her to contact a fertility clinic offering $1500 for her... more
... 234 Glenn McGee, Jessica Anchor and Arthur Caplan easy money. Barbara Nevins writes, for example, of one college student who had a credit card bill of $3000, prompting her to contact a fertility clinic offering $1500 for her eggs." I didn't worry about the emotional things," she ...
Research Interests:
Research Interests:
Research Interests:
Research Interests: Cardiology, Medical Ethics, Adolescent, Medicine, Humans, and 15 moreChild, Genetic Testing, Infant, Marfan syndrome, Long QT syndrome, Clinical Sciences, Aged, Genotype, Adult, Cardiomyopathy, Circulation, Hypertrophic Cardiomyopathy, Child preschool, genetic heterogeneity, and Cardiovascular medicine and haematology
To the editor: In his essay, "The Point of a Ban: Or, How to Think About Stem Cell Research" (HCR, January-February 2001), Gilbert Meilaender examines and challenges our interpretation of the applicability of just war theory to... more
To the editor: In his essay, "The Point of a Ban: Or, How to Think About Stem Cell Research" (HCR, January-February 2001), Gilbert Meilaender examines and challenges our interpretation of the applicability of just war theory to stem cell research ("Small Sacrifices in Stem Cell Research," Kennedy Institute of Ethics Journal 9, no. 2 (1999): pp. 151-58). Meilaender concurs with Michael Walzer that in order for a war, fought in defense of a good cause, to be just, it must involve an "almost inviolable" commitment to a convention of deontological principles of war. Nonetheless, Walzer and Meilaender acknowledge that there sometimes comes "[a] moment when we must reason in accord with a utilitarianism of extremity and override them." Drawing on examples of great violence culled from World War II, Meilaender describes supreme emergencies, concluding that stem cell research (involving embryos) has been shown neither to constitute a strategic necessity in medicine, nor a moral imperative. We concede that if one frames stem cell research as a battle in which human lives are to be sacrificed in the interest of conquering disease, one invites a slippery slope (which diseases? how many lives?) that might lead to the decimation of basic human obligations. But the point of our argument was not only about the reality of sacrifice in some circumstances, but also that the nature of the sacrifice of human embryos is not known in embryonic stem cell research. In no obvious sense are there embryos destroyed by the harvesting of stem cells. In most cases, we argue, the potential and/or life of the embryo is in fact extended by transplanting its genetic material. Meilaender acknowledges that we make this claim, but discusses it only in a footnote in which he states that problems of identity are raised by our claim. He does not take these problems up, instead making the incorrect assumption that the sacrifice we endorse is one morally equivalent to that made at Hiroshima or in asking troops to die in conflicts such as the Battle of the Bulge or the Persian Gulf War. While it is obviously not possible to debate the impact of biological development and new technology on the moral status of the embryo in a letter, we would note that it is ironic that Meilaender seems to eschew every opportunity for a commensurable conversation about the moral meaning of stem cell research, opting instead to defend a temporary ban on what seems to us to be simple grounds of expediency. Meilaender's peculiar argument from The Screwtape Letters to the effect that long life is not necessarily better life does justice neither to the meaning of suffering for those tens of millions suffering from degenerative disease and paralysis, nor to the investigation that we propose into how best to understand the nature of sacrifice in stem cell research. From opposite sides of the aisle, both NBAC and Meilaender attempt to do the impossible: to resolve the stem cell debate without dealing at all with the moral status of the embryo. …
Research Interests:
Research Interests:
... 106 GLENN MCGEE Philosopher's Index and the Education Indices). Among 257 English language articles published between 1994-98 that cited both Dewey and James, and appeared in journals with a" high scholarly... more
... 106 GLENN MCGEE Philosopher's Index and the Education Indices). Among 257 English language articles published between 1994-98 that cited both Dewey and James, and appeared in journals with a" high scholarly impact"(according to ISI, the US organization that ranks ...
Research Interests:
Research Interests:
The regulation of e-cigarettes and the e-liquids they deliver has proved challenging for the US Food and Drug Administration given the relatively short time these products have been widely distributed and the inconclusive data about their... more
The regulation of e-cigarettes and the e-liquids they deliver has proved challenging for the US Food and Drug Administration given the relatively short time these products have been widely distributed and the inconclusive data about their effects on human health. While conventional tobacco cigarette use continues to drop among adults and teenagers, e-cigarette use has skyrocketed, particularly among school aged children and young adults.
Research Interests:
With the mapping of the human genome and the development of cloning and other genetic engineering techniques, scientists have embarked upon a whole new era of biomedical research and with it a maze of complex ethical and legal questions.... more
With the mapping of the human genome and the development of cloning and other genetic engineering techniques, scientists have embarked upon a whole new era of biomedical research and with it a maze of complex ethical and legal questions. This excellent collection of articles by scientists, ethicists, and legal experts analyses the convergence of biotechnology and intellectual property legislation, which has given rise to these new moral dilemmas. It will serve as a valuable reference work to give educated lay readers a starting point to make their own judgements about matters we will all face in the near future.
Research Interests:
... 106 GLENN MCGEE Philosopher's Index and the Education Indices). Among 257 English language articles published between 1994-98 that cited both Dewey and James, and appeared in journals with a" high scholarly... more
... 106 GLENN MCGEE Philosopher's Index and the Education Indices). Among 257 English language articles published between 1994-98 that cited both Dewey and James, and appeared in journals with a" high scholarly impact"(according to ISI, the US organization that ranks ...
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Scholars of differing political affiliation and the President's Council on Bioethics have called for regulation of assisted reproductive technology (ART) that would emulate many aspects of the regulatory system of the United Kingdom,... more
Scholars of differing political affiliation and the President's Council on Bioethics have called for regulation of assisted reproductive technology (ART) that would emulate many aspects of the regulatory system of the United Kingdom, in particular that of the Human Fertilisation and Embryology Authority. Specifically, scholars and the Council have argued that research in the U.S. involving gametes and human embryos lacks consistent oversight. While the Centers for Disease Control and Prevention (CDC) produces an annual ART success rate report, submission of data is guaranteed only by the promise that non-responders will be noted as such in the appendix of CDC's report, and most ART clinics publish success rates on the Internet in a much more recognized forum: website advertising. Moreover, U.S. law does not require licensing or accreditation of infertility programs and few regulations govern embryo research. While the large majority of clinics report their success rate data,...
Research Interests: Sociology, Law, Bioethics, Political Science, Accreditation, and 15 moreReproductive Technology, Medicine, Policy making, Humans, Legislation, United States, Assisted Reproductive Technology, Newspaper, American, Bioethics Reproductive Technology, Great Britain, LICENSE, Publication, Full Text Vol 5, and Government Regulation
Research Interests:
Comment on LF Ross.
Research Interests:
ABSTRACT The American Journal of Bioethics 1.1 (2001) 1 On behalf of The MIT Press and the Editorial Staff at the University of Pennsylvania Center for Bioethics, we welcome you to The American Journal of Bioethics and thank you for... more
ABSTRACT The American Journal of Bioethics 1.1 (2001) 1 On behalf of The MIT Press and the Editorial Staff at the University of Pennsylvania Center for Bioethics, we welcome you to The American Journal of Bioethics and thank you for participating in an experiment. We have been surprised at the quality and number of scholars who agreed to participate in these first issues, and overwhelmed by good will from all corners. There is a greater than minimal risk for any who join a new publication, but it is our hope that in the coming months your efforts will bring scholars, institutions, and methods together for a unique dialogue. Our hope is that The American Journal of Bioethics will demonstrate a direct benefit to you. To be effective, bioethics must cross the many boundaries that separate disciplines, methods, and style of publication. There has never been more discussion of bioethics or more obvious need for broad public debate, but, paradoxically, specialization and sub-specialization in publishing has reached its zenith. The challenge of publishing in bioethics is a real and significant one: research of interest to a broad audience often needs to reach scholars in a special discipline, but also has implications that are sweeping for many in law, medicine, nursing, and public policy. This is the case, for example, with new technologies for sex selection, as is discussed in this issue. AJOBpublishes "Target Articles" on interesting, important, and timely topics. For each Target Article, we publish 15 to 20 "Open Peer Commentary" articles. Taking advantage of the power of the Internet in the production of AJOB, a group of scholars comment in an evolving discussion about the Target Article. In this first issue, we are pleased that so many prominent scholars have joined the discussion. Future issues include interaction focused on refining and synthesizing bioethics (normative philosophical work alongside data-driven papers, literary analysis combined with ethnography), and different approaches to the problems of health and science as they impact the work of bioethics. AJOB also seeks out work that embodies imaginative scholarship in more traditional publishing formats: Warren Reich's fine piece on the concept of care in Nazi Germany has important lessons for contemporary medicine and bioethics. Future issues will include book reviews and other more innovative features. Our Internet site (AJOBonline) includes not only the contents in the print version, but such innovative features as a web portal to keep you updated on news, an online bioethics bookstore, tables of contents for more than two dozen journals, a live classroom to allow your students to join the debate with our authors, and other online-only content. We are very grateful to all of the people at Penn and the MIT Press who have invested labor and love in this experiment. Our team of Managing Editors, staff, and supporters at Penn since the inception of this idea have given tirelessly to an endeavor that one described as inventing the wheel. Our editorial board and many authors have contributed effort that vastly exceeds the duties ordinarily expected in such roles. Now, we hope the benefits of the journal will outweigh the burden of your investment!
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
... Director, Humantics Foundation. by Ilena Rosenthal [Comment posted 2007-08-21 18:20:09]. This article made some excellent points. ... Mounting deaths and injuries are downplayed as mere "side effects" and... more
... Director, Humantics Foundation. by Ilena Rosenthal [Comment posted 2007-08-21 18:20:09]. This article made some excellent points. ... Mounting deaths and injuries are downplayed as mere "side effects" and "complications." The death of a young woman from a blood clot three ...
Research Interests:
Too much contemporary bioethical discourse is weak on science, lazily citing and adopting science fiction scenarios rather than science facts in the framing of analyses and policies. We challenge bioethicists to take more seriously the... more
Too much contemporary bioethical discourse is weak on science, lazily citing and adopting science fiction scenarios rather than science facts in the framing of analyses and policies. We challenge bioethicists to take more seriously the role of providing informed insight into and oversight over contemporary science and its implications and applications. Bioethicists must work harder to understand the fast-changing truths and limits of basic science, and they must incorporate only appropriate and authentic science into their discourse, just as they did in the past when addressing the quandaries of clinical medicine. The field of bioethics is not so old and entrenched that its future is assured. Bioethicists must make themselves useful to society in order to deserve and retain the public's trust. They can best do this by ensuring that decision making and public policy are grounded in facts, not fictions and fantasies.
Research Interests: Applied Ethics, Public Opinion, Bioethics, Decision Making, Evidence Based Medicine, and 15 moreClinical Trial, Science, Gene Therapy, Science Fiction, Health Policy, Medicine, Social Responsibility, Policy making, Humans, Advisory Committees, Public health systems and services research, Gene Transfer, Public Policy, Ethical Analysis, and Genetic Therapy
Comment on LF Ross.
Research Interests:
Research Interests:
Research Interests: Psychology, Philosophy, Ethics, Applied Ethics, Parenting, and 15 moreRisk assessment, Medicine, Social Responsibility, Genetic Engineering, Humans, Eugenics, Genetic Enhancement, Attitude, Goals, Genetic determinism, Parents, Risk Assessment, Choice Behavior, Personal autonomy, and Professional Role
Over the last several years, substantial progress has been achieved in defining the molecular basis for several genetically transmitted, nonatherosclerotic cardiovascular diseases. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22... more
Over the last several years, substantial progress has been achieved in defining the molecular basis for several genetically transmitted, nonatherosclerotic cardiovascular diseases. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ...
Research Interests: Adolescent, Medicine, Humans, Child, Genetic Testing, and 15 moreInfant, Marfan syndrome, Long QT syndrome, Phenotype, Clinical Sciences, Aged, Middle Aged, Genotype, Adult, Public health systems and services research, Circulation, Hypertrophic Cardiomyopathy, Child preschool, genetic heterogeneity, and Cardiovascular medicine and haematology
... Login. THE HUMAN CLONING DEBATE. Show full item record. Title: THE HUMAN CLONING DEBATE. Author: McGee, Glenn and Caplan, Arthur, eds. Description: Fourth edition BRL location: library BRL special collection: GenETHX. ...
Research Interests:
Research Interests: Applied Ethics, Conflict of Interest, Investments, Humans, United States, and 11 morePhysicians, Risk factors, Cardiovascular system, Public health systems and services research, Risk Factors, Scientific Misconduct, Drug Industry, Lactones, Equipment and Supplies, United States Food and Drug Administration, and Physician-Patient Relations
Page 1. Conflict of Interest and AJOB Kelly A. Carroll, Executive Managing Editor, ... It is clear that the choice of research topics by investigators can be influenced by the lure of easy funding or the opportunity to work with an... more
Page 1. Conflict of Interest and AJOB Kelly A. Carroll, Executive Managing Editor, ... It is clear that the choice of research topics by investigators can be influenced by the lure of easy funding or the opportunity to work with an investi-gator or funder who controls it. ...
Research Interests:
Conceived as a solution to clinical dilemmas, and now required by organizations for hospital accreditation, ethics committees have been subject only to small-scale studies. The wide use of ethics committees and the diverse roles they have... more
Conceived as a solution to clinical dilemmas, and now required by organizations for hospital accreditation, ethics committees have been subject only to small-scale studies. The wide use of ethics committees and the diverse roles they have played compel study. In 1999 the University of Pennsylvania Ethics Committee Research Group (ECRG) completed the first national survey of the presence, composition, and activities of U.S. healthcare ethics committees (HECs). Ethics committees are relatively young, on average seven years in operation. Eighty-six percent of ethics committees report that they played a role in ongoing clinical decision making through clinical ethics consultation. All are engaged in developing institutional clinical policy. Although 4.5% of HECs write policy on managed care, 50% of HEC chairs feel inadequately prepared to address managed care. The power and activity of ethics committees parallels the composition of those committees and the relationship of members to their institutions. The role of ethics committees across the nation in making policies about clinical care is greater than was known, and ethics committees will likely continue to play an important role in the debate and resolution of clinical cases and clinical policies.
Research Interests:
... Anthony Graybosch, Michael Hodges, Eric Juengst, Jacqueline Kegley, Dick Lewontin and John McDermott each gave time, energy, and ideas to the project. Jeffrey Tlumak was an invaluable sources of support and encouragement, as were... more
... Anthony Graybosch, Michael Hodges, Eric Juengst, Jacqueline Kegley, Dick Lewontin and John McDermott each gave time, energy, and ideas to the project. Jeffrey Tlumak was an invaluable sources of support and encouragement, as were Christie Allen, Micah Hester, Phillip ...